You just bought a company, lodo therapeutics. Tell me about what that company does and why you bought it. One of the things that we're always on the lookout for are sources of novel genetic diversity. And this becomes useful for creating novel geans,. refining novel geans, creating clusters of genes that make novel products, et cetera....
Jason opens with a Founder University segment on "Startup Math" (1:48), then interviews Zymergen CEO Josh Hoffman on Biofacturing (16:45), how DNA sequencing & machine learning are enabling materials science advancements (26:35), what human capital is needed for the industry (42:53) & more. Pod Notes: http://bit.ly/1231notes